BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,278,934 | +58.8% | 33,888 | +91.7% | 0.08% | -17.2% |
| Q2 2023 | $805,364 | -46.8% | 17,677 | -51.5% | 0.10% | +1.0% |
| Q1 2023 | $1,512,516 | +60.6% | 36,449 | +97.3% | 0.10% | -21.6% |
| Q4 2022 | $941,518 | -12.0% | 18,472 | -7.2% | 0.12% | -10.1% |
| Q3 2022 | $1,070,000 | -11.1% | 19,914 | -0.8% | 0.14% | -7.3% |
| Q2 2022 | $1,203,000 | -16.7% | 20,067 | 0.0% | 0.15% | -21.5% |
| Q1 2022 | $1,445,000 | -16.1% | 20,067 | 0.0% | 0.19% | -0.5% |
| Q4 2021 | $1,723,000 | +4.5% | 20,067 | -0.5% | 0.19% | +2.7% |
| Q3 2021 | $1,649,000 | +8.8% | 20,167 | -0.0% | 0.19% | +6.9% |
| Q2 2021 | $1,516,000 | -12.8% | 20,172 | -0.6% | 0.18% | -17.1% |
| Q1 2021 | $1,738,000 | +5.9% | 20,287 | -3.7% | 0.21% | -2.8% |
| Q4 2020 | $1,641,000 | -3.8% | 21,072 | -0.6% | 0.22% | -15.9% |
| Q3 2020 | $1,705,000 | -8.3% | 21,203 | -1.9% | 0.26% | -16.8% |
| Q2 2020 | $1,860,000 | +6.0% | 21,603 | 0.0% | 0.31% | -9.9% |
| Q1 2020 | $1,754,000 | -2.9% | 21,603 | 0.0% | 0.34% | +19.4% |
| Q4 2019 | $1,806,000 | -6.4% | 21,603 | -2.1% | 0.29% | -14.8% |
| Q3 2019 | $1,930,000 | +5.9% | 22,066 | -0.8% | 0.34% | +3.4% |
| Q2 2019 | $1,822,000 | -4.8% | 22,247 | -5.5% | 0.33% | -8.1% |
| Q1 2019 | $1,914,000 | +20.2% | 23,537 | -2.7% | 0.36% | +8.2% |
| Q4 2018 | $1,593,000 | -16.0% | 24,195 | -1.6% | 0.33% | -11.6% |
| Q3 2018 | $1,896,000 | -2.8% | 24,600 | -6.8% | 0.37% | -9.7% |
| Q2 2018 | $1,950,000 | +13.2% | 26,409 | -0.2% | 0.41% | +10.5% |
| Q1 2018 | $1,722,000 | +0.1% | 26,469 | -0.5% | 0.37% | +1.6% |
| Q4 2017 | $1,720,000 | +2.2% | 26,614 | -0.7% | 0.37% | -3.2% |
| Q3 2017 | $1,683,000 | -5.7% | 26,814 | -9.0% | 0.38% | -8.0% |
| Q2 2017 | $1,785,000 | +15.5% | 29,477 | -1.0% | 0.41% | +12.6% |
| Q1 2017 | $1,545,000 | +16.0% | 29,787 | -0.8% | 0.37% | +6.4% |
| Q4 2016 | $1,332,000 | -4.4% | 30,030 | +2.6% | 0.34% | -9.0% |
| Q3 2016 | $1,393,000 | +3.2% | 29,255 | -2.0% | 0.38% | +0.8% |
| Q2 2016 | $1,350,000 | +8.3% | 29,862 | -1.6% | 0.38% | +3.9% |
| Q1 2016 | $1,246,000 | +5.3% | 30,342 | -2.1% | 0.36% | +2.3% |
| Q4 2015 | $1,183,000 | -9.1% | 31,007 | -21.8% | 0.35% | -18.5% |
| Q3 2015 | $1,302,000 | -57.2% | 39,641 | -8.9% | 0.43% | -54.8% |
| Q2 2015 | $3,042,000 | – | 43,494 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |